Deutsche Bank Ag\ Beyond Air, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

A detailed history of Deutsche Bank Ag\ transactions in Beyond Air, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 403,252 shares of XAIR stock, worth $209,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares

403,252

Previous 400,000 0.81%

Holding current value

$209,691

Previous $696,000 68.82%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.54 - $1.67 $1,756 - $5,430	3,252 Added 0.81%	403,252 $217,000
Q1 2024 May 15, 2024	SELL	$1.3 - $2.15 $20,788 - $34,380	-15,991 Reduced 3.84%	400,000 $696,000
Q4 2023 Feb 14, 2024	BUY	$1.4 - $2.46 $11,796 - $20,727	8,426 Added 2.07%	415,991 $815,000
Q3 2023 Nov 09, 2023	BUY	$2.31 - $4.18 $17,475 - $31,621	7,565 Added 1.89%	407,565 $941,000
Q2 2023 Aug 14, 2023	BUY	$4.26 - $6.92 $1.7 Million - $2.77 Million	400,000 New	400,000 $1.7 Million
Q4 2021 Feb 11, 2022	SELL	$8.44 - $15.61 $10,279 - $19,012	-1,218 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$5.9 - $12.54 $7,144 - $15,185	1,211 Added 17300.0%	1,218 $14,000
Q2 2021 Aug 11, 2021	SELL	$4.72 - $7.15 $42,749 - $64,757	-9,057 Reduced 99.92%	7 $0
Q1 2021 May 13, 2021	SELL	$5.13 - $7.24 $13,389 - $18,896	-2,610 Reduced 22.36%	9,064 $49,000
Q4 2020 Feb 16, 2021	BUY	$5.18 - $6.03 $25,936 - $30,192	5,007 Added 75.1%	11,674 $61,000
Q3 2020 Nov 12, 2020	BUY	$4.86 - $7.07 $3,144 - $4,574	647 Added 10.75%	6,667 $34,000
Q2 2020 Aug 13, 2020	BUY	$6.44 - $9.45 $38,768 - $56,888	6,020 New	6,020 $44,000

Others Institutions Holding XAIR

# of Institutions

Shares Held

11.1M

Call Options Held

54.4K

Put Options Held

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $15.5M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account